All News

An experimental drug that stabilizes a protein protects human bladder cells against a major UTI pathogen, researchers say.

Having completed a well-deserved victory lap after the recent repeal of the SGR, it's time to tune up our engines and head right back to the race track to advance the specialty's remaining advocacy priorities.

Hear what urologists are doing to enhance their income and practice.

Finally, I can stop writing about the Medicare SGR formula and efforts to reform it, and you can stop worrying about whether you’re going to get whacked with untenable payment cuts about this time every year.

A patient follow-up report shows promising mid-term results from five German urology centers that implemented the prostatic urethral lift (UroLift System, NeoTract, Inc.) to alleviate symptomatic BPH in patients suffering from mild, moderate, and even severe obstruction.

Biomarker models to predict disease progression in prostate cancer have a promising future, but at present, they have not fully justified their claimed clinical utilities, according to the authors of an independent review and analysis of the literature.

Near-infrared fluorescence-guided selective clamping with indocyanine green fluorescent dye in robot-assisted partial nephrectomy appears to be a promising technique to delineate renal tumor anatomy for the bloodless resection of renal masses while minimizing ischemic damage to the kidney.

Not-so-obvious coding errors and self-referral practices are a growing target for the government and contractors, health care attorneys say.

What can urologists do to protect themselves from being accused of and charged with health care fraud and abuse? Urologist Jeffrey Kaufman, MD, and attorneys J.D. Thomas, Esq and Laura F. Laemmle-Weidenfeld, Esq provide these four suggestions.

Remaining on preventive antiplatelet therapy with aspirin significantly increases the risk of bleeding complications in patients undergoing partial nephrectomy, according to research presented at the European Association of Urology annual congress in Madrid, Spain.

In this article, Robert A. Dowling, MD, discusses additional opportunities for urologists to improve the safety of care in their own practices in the context of the NQF best practices.

In this Coding Q&A column, the Painters discuss the tricky question of whether you can bill for stone prevention counseling, and also answer a question about whether you can bill two instillation codes (51700) for one appointment.

Other products featured include a spacer system to protect men undergoing PCa radiotherapy, a pelvic floor exercise app, and more.

I am more optimistic that we will find a way to treat those who truly need to be treated and follow those unlikely to die from their disease.

In this article, James M. Hotaling, MD, MS, outlines the elements that comprise a cost-effective workup of the infertile male patient.

Latest news, updates, and highlights right from AUA 2015

A newly published review suggests that age-related testosterone deficiency treatment with intramuscular injections of testosterone replacement therapy offers health benefits and lower cardiovascular risk compared to testosterone replacement by patch or gel.

Placement of a nerve “wrap” around the neurovascular bundle during nerve-sparing robot-assisted radical prostatectomy appears to accelerate the early restoration of continence and potency following surgery, a recently published study has shown.

Other products featured include a digital card enabling mobile payment functionality, an imaging method for bladder biopsy, a surgical plume evacuation pencil, a video to help prepare patients for surgery, and more.

Listen to the interview of Dr. Neil Baum share his top five places to eat and attractions you won't want to miss out on while attending the 2015 AUA annual meeting.

Two case studies of stereotactic ablative radiation therapy yielded survival times comparable to those seen with surgical treatment.

Legislation that ends the sustainable growth rate (SGR) formula was hailed by leading urology groups as a historic, watershed event.

If you continue to own appreciated capital assets until you or your spouse dies, the tax consequence could be greatly reduced, or maybe even completely eliminated, when the assets are eventually sold, courtesy of Section 1014(a) of the Internal Revenue Code, which generally allows an unlimited federal income tax basis step-up for appreciated capital assets owned by a person who passes away.

Products in the pipeline for prostate cancer, bladder cancer, stress urinary incontinence, chronic prostatitis/chronic pelvic pain syndrome, hypoactive sexual desire disorder.

Although significant time is spent developing methods or strategies that come close to that “perfect investment," none is as popular or compelling as modern portfolio theory.

To help you maximize your AUA experience, Urology Times’ editorial board and other thought leaders have pored over hundreds of abstracts to identify the key trends and can’t-miss research from this year’s meeting.

Statins may improve outcomes in hormone-sensitive prostate cancer, and one possible mechanism responsible may have been discovered.

The findings could help clinicians differentiate between slow-growing and aggressive tumors